Skip to main content
Full access
Letters to the Editor
Published Online: 5 January 2018

More Efforts Needed to Clarify the Effect of Lithium in Bipolar Disorder: Response to Terao et al.

To the Editor: We thank Dr. Terao and colleagues for raising important points about our study (1). They have noticed that the reduced rate of suicide-related events during lithium treatment that we saw in persons with bipolar disorder was in fact not statistically significant in the subgroup of patients with bipolar I disorder. They submit that this detail might be explained by including patients with mixed episodes in this group, and they propose that we rediagnose patients according to DSM-5 using the mixed features specifier and rerun analyses.
Unfortunately, our study was based on national registers that do not have symptom-level data available. This precludes us from rediagnosing patients according to DSM-5. However, we have repeated the analyses for the bipolar I and II subtypes of bipolar disorder while excluding patients diagnosed with mixed episodes according to ICD-10 (F316). The results are shown in Table 1.
TABLE 1. Risk of Suicide-Related Events During Periods of Lithium Treatment Compared With Periods Without Lithium Treatment in Patients With Bipolar Disorder Who Have Not Been Diagnosed With a Mixed Episode (2005–2013)
Patient GroupWithin-Individual AnalysisaBetween-Individual Analysisb
Hazard Ratio95% CIHazard Ratio95% CI
Any bipolar disorder, excluding patients with mixed episodesc0.820.73–0.930.800.72–0.89
Bipolar I disorder, excluding patients with mixed episodes0.740.49–1.110.730.55–0.98
Bipolar II disorder, excluding patients with mixed episodes0.550.38–0.800.730.53–0.99
a
Stratified Cox regression was applied with adjustment for time-varying covariates including valproate treatment, age categories, and previous number of suicide attempts.
b
Ordinary Cox regression was applied with adjustment for the same covariates as in the stratified Cox regression and, additionally, with adjustment for time-fixed covariates including sex, length of baseline hospitalization periods due to psychiatric admissions (a measure of illness severity), and history of suicide-related events before entering follow-up.
c
This group includes all patients with bipolar disorder identified in the patient register regardless of subtype (i.e., including bipolar disorder not otherwise specified). The mixed episode was identified using ICD-10 (F316).
For all patients without mixed episodes, lithium treatment was significantly associated with reduced suicide-related events. And in line with Dr. Terao and colleagues’ suggestion, the effect of lithium on the rate of suicide-related events increased in both bipolar I and bipolar II disorder when patients diagnosed with mixed episodes were excluded (1). However, the association remained nonsignificant for patients with bipolar I disorder. Two points should be noted, however. First, even though the patient register uses ICD-10 codes, many clinicians in Sweden used DSM-IV and translated diagnoses to ICD-10. In addition, DSM-IV requires that the criteria for both depression and mania be met (except the time criterion) in order to diagnose a mixed episode. This means that it is still possible that the bipolar I disorder group contains individuals with mixed features according to DSM-5. Thus, we cannot refute Dr. Terao and colleagues’ suggestion. Future studies using DSM-5 criteria are needed to answer their question. Second, because ICD-10 does not distinguish between bipolar I and bipolar II disorder, we used data from a quality register for the subgroup analyses. This quality register contains only one-third of all Swedish patients with bipolar disorder, which decreases the size of the study sample. Thus, the fact that the results in bipolar I disorder do not reach statistical significance might be a power issue. Therefore, we agree with Terao et al. that more efforts are needed to explore the effect of lithium in preventing suicidal behavior in specific subgroups, where not only the subtype of bipolar disorder is taken into account, but also mixed features.

Reference

1.
Song J, Sjölander A, Joas E, et al: Suicidal behavior during lithium and valproate treatment: a within-individual 8-year prospective study of 50,000 patients with bipolar disorder. Am J Psychiatry 2017; 174:795–802

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 80 - 81
PubMed: 29301431

History

Accepted: September 2017
Published in print: January 01, 2018
Published online: 5 January 2018

Keywords

  1. Anticonvulsants
  2. Epidemiology
  3. Lithium
  4. Mood Disorders-Bipolar
  5. Suicide

Authors

Details

Mikael Landén, M.D., Ph.D.
From the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm; and the Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden.
Jie Song, Ph.D. [email protected]
From the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm; and the Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden.

Notes

Address correspondence to Dr. Song ([email protected]).

Funding Information

The authors’ disclosures accompany the original article.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share